Литература


Литература

  1. Каспер С. Обоснование длительной терапии антидепрессантами//Соц. и Клин, психиатрия 1995, № 1, с. 80-91.
  2. Мосолов С. Н. Клиническое применение современных антидепрессантов. C-Пб, Мед. инфор. агенство, 1995, с. 486.
  3. Мосолов С. Н., Смулевич А. Б., Нуллер Ю. Л. и др. Клиническая эффективность и переносимость препарата Паксил (пароксетин) при лечении умеренной и тяжелой депрессии// Новые достижения в терапии психических расстройств. М. 2002, с. 266-278.
  4. Мосолов С. Н., Вертоградова О. П., Пантелеева Г. П. и др. Профилактическая эффективность тианептина при РДР с частыми обострениями//Журн.невролог. и психиатр, им. С. С. Корсакова, 2004, № 9, с. 32-39.
  5. Тювина Н. А., Крук Я. В. Сравнительное исследование эффективности амитриптилина, финлепсина и коаксила при профилактической терапии рекуррентного депрессивного расстройства//Психиатрия и психофармакотерапия, 2005, Том 7, № 3, с. 160-164
  6. Altamura С. A., Percudanti М. The use of antidepressants for long-term treatment of recurrent depression//J. Clin. Psychiat., 1993, Vol 58, № 8 (suppl.), p. 29-35.
  7. Christiansen P. E. Paroxetine and imipramine in treatment of depressed patients in psychiatric specialist practice//Nord.J. Psychiat., 1992, Vol. 46, Suppl. 27, p. 33-39.
  8. Claghorn J. L. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients//J. Clin. Psychiat., 1992, Vol. 53 (Suppl.), p. 33-35.
  9. Claghorn J. L. Feighner J. P. A double-blind comparison of paroxetine with imipramine in the long-treatment of depression//J. Clin. Psychopharmacology, 1993, Vol. 13 (Suppl. 2), p. 23-33.
  10. Coppen A., Chose K., Montgomery S. et al. Continuation therapy with amitriptiline in depression//Brit.J. Psychiat., 1978, Vol. 133, p. 28-33
  11. Dalery J., Dagens-Lafant V, De Bodinat C. Efficacy of tianeptine versus placebo in long-term treatment (16,5 months) of unipolar major recurrent depression//Encephale 1997, Vol. 23, p. 56-64
  12. Dunbar G. C., Claghorn J. L., Kiev A. et al. A comparison of paroxetine and placebo in depressed outpatients//Acta Psychiatrica Scandinavica, 1993, Vol. 87, p. 302-305.
  13. Doogan D. P, Caillard V Sertraline in the prevention of relapse in major depression// Psychopharmacology, 1998, Vol. 96 (Suppl.), p. 271.
  14. Diagnostic and statistical manual of mental disorders – IV-TR, 2000, p.817-818.
  15. Feldman H. S., Denber H.S. Long-term study of fluvoxamine: a new rapid-acting antidepressant//Int. Pharmacopsychiat, 1982, Vol. 17, p. 114-122.
  16. Franchini L., Gasperini M., Perez J. et al. Dose-response efficacy of paroxetine in preventing depressive recurrences: A randomized, double-blind study//J. Clin. Psychiatry, 1998, Vol. 59, № 5, p. 229-232.
  17. Frank E., Kupfer D.J., PerelJ.M. et al. Three-year outcome for maintenance therapies in recurrent depression//Arch. Gen. Psychiatry, 1990, Vol. 47, p. 1093-1099.
  18. Gilaberte I., Montejo A. L., de la Gandara J. et al. Fluoxetine in the prevention of depressive recurrences: a double-blind study//J. Clin Pharmacologycal, 2001, Vol. 21, p. 417-424
  19. Glen A. I. M., Jonhson A. L., Shepherd M. Continuation therapy with lithium and amitriptiline in unipolar depressive illness: a randomized double-controlled trial//Psychol. Med. 1984, Vol. 14, p. 37-50.
  20. Hochstrasser B., Isakens P. M., Koponen H. et al. Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy//Br.J. Psychiatry, 2001, Vol. 178, p. 304-310.
  21. Kupfer D.J., Frank E., PerelJ.M. et al. Five-year outcome for maintenance therapies in recurrent depression//Arch. Gen. Psychiat., 1992, Vol. 49, p. 769-773.
  22. Loo H., Dufour J.D. et al. Long-term use of tianeptine in 380 depressed patients// Br.J. Psychiatry, 1992, Vol. 160 (suppl. 15), p. 61-65
  23. Montgomery S. A., Dufour H., Brien S. et al. The prophylactic use of fluoxetine in unipolar depression//Brit.J. Psychiat., 1988, Vol. 153, p. 69-76.
  24. Montgomery S. A, Doogan D. P, Burnside R. The influence of different relapse criteria on assessment of the long-term efficacy of sertraline//Int Clin. Psychopharmacol., 1991, Vol. 6 (suppl. 2), p. 37-46.
  25. Montgomery S. A., Dunbar G.J. Paroxetine is better tolerated then placebo in relapse prevention and the prophylaxis of recurrent depression//Clin. Psychopharmacology, 1993, Vol. 8, p. 189-195.
  26. Montgomery S. A., Rasmussen J. G. C., Tanghoj P. A. 2-week study of 20 mg Citalopram, 40 mg Citalopram and placebo in prevention of relapse of major depression//Inter. Clin. Psychopharmacol., 1993, Vol. 8, p. 181-188.
  27. Montgomery S. A. Treatment of recurrent depression//WPA Bulletin on Depression, 2004, Vol. 7, № 26, p. 6-7.
  28. Ohrberg S, Christiansen P. E., Severin B. et al. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice//Acta Psychiatr Scand., 1992, Vol. 86, N° 6, p. 437-444.
  29. Sergeant J. K., Bruce M. L., Florio L. P. et al. Factors associated with 1-year outcome of major depression in the community//Arch. Gen. Psychiatry, 1990, Vol. 47, p. 510-515
  30. Terra J.L., Montgomery S.A. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study//Int. Clin. Psychopharmacol., 1998, Vol. 13, p. 55-62.
  31. Tylee A. Depression in Europe: experience from DEPRES II survey//Europ. Psychychopharm., 2000, Vol. 10, suppl. 4, p. 445-448.

Если вы нашли ошибку, пожалуйста, выделите фрагмент текста и нажмите Ctrl+Enter.